Precio de cierre
Otros sitios de cotización
|
||
- | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jun-Su Lee
CEO | Chief Executive Officer | 51 | 07/12/18 |
Sung-Ho Jin
BRD | Director/Board Member | 61 | 01/03/01 |
Sun-Min Im
AUD | Comptroller/Controller/Auditor | 75 | 28/03/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 60 | 28/03/14 | |
Jong-Wuk Lee
BRD | Director/Board Member | 64 | 16/03/12 |
Kevin Bain
BRD | Director/Board Member | 66 | 13/12/12 |
Bang-Boo Yoon
BRD | Director/Board Member | 81 | 16/03/12 |
Sung-Ho Jin
BRD | Director/Board Member | 61 | 01/03/01 |
Peta Bazarov
BRD | Director/Board Member | 49 | 27/03/15 |
Jun-Su Lee
CEO | Chief Executive Officer | 51 | 07/12/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 11 857 922 | 922 240 ( 7,777 %) | 0 | 7,777 % |
Información de la empresa
Alvogen Korea Co., Ltd.
13th Floor, 10 Gukjegeumyung-ro Yeongdeungpo-gu
07326, Seoul
+
http://www.alvogenkorea.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+21,09 % | 43,27 mil M | |
+25,28 % | 22,92 mil M | |
+19,22 % | 15,43 mil M | |
+13,51 % | 12,95 mil M | |
+44,01 % | 11,83 mil M | |
-7,79 % | 6910,99 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+13,02 % | 5549,91 M |
- Bolsa de valores
- Acciones
- Acción
- Empresa KUNWHA Pharmaceutical Co., Ltd.